A peer-reviewed head-to-head study of free ML screening tools found Rayyan highest overall, with the best sensitivity and lowest false-negative rate.

68 Cochrane Reviews cite Rayyan in full text, three times the next tool. What adoption by the most scrutinized authors in evidence synthesis tells you.

PROSPERO registry data shows Rayyan became the #1 named screening tool for new systematic review protocols in 2025. Here is the full public record.